A Task Force Report of the American Psychiatric Association
American Psychiatric Association
Since the APA's last report on tardive dyskinesia in 1979, considerable research has been conducted on the prevalence, incidence, and risk factors associated with the development of late-occurring neuroleptic side effects. This book summarizes the progress made over the last decade in understanding the differential diagnosis and epidemiology of tardive dyskinesia, as well as risk factors, course, and treatment.
The reader will benefit from the book’s coverage of
- indications for neuroleptic use
- alternative maintenance strategies
- factors to consider in making a differential diagnosis
- frequently encountered problems in dealing with special populations such as children and mentally retarded people
- clinical-legal issues related to tardive dyskinesia
- clearly specified recommendations for prevention and management
Differential diagnosis of tardive dyskinesia. Assessment of tardive dyskinesia. Epidemiology, risk factors, and outcome of tardive dyskinesia. Treatment of tardive dyskinesia. Neuroleptic drugs: indications, efficacy, and therapeutic dosages. Alternative maintenance treatment strategies: clinical efficacy and impact on tardive dyskinesia. Alternatives to neuroleptic drug therapy. Are there behavioral analogues of tardive dyskinesia? Clinical-legal issues. Research recommendations. Summary, conclusions, and recommendations for the prevention and management of tardive dyskinesia. Appendix: sample rating scales.
"This is a clearly written task force report that sets out a high community standard and places it in the context of future scientific research as the treatment of patients with severe mental illness evolves."—Psychosomatics